全球兽医参考实验室市场按服务、应用、动物类型、最终用户和地区划分-预测至2030年
市场调查报告书
商品编码
1881286

全球兽医参考实验室市场按服务、应用、动物类型、最终用户和地区划分-预测至2030年

Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030

出版日期: | 出版商: MarketsandMarkets | 英文 606 Pages | 订单完成后即时交付

价格

预计兽医参考实验室市场规模将从 2025 年的 475 万美元增长到 2030 年的 646 万美元,复合年增长率为 6.3%。

感染疾病和慢性动物疾病的增加、通用动物饲养率的提高以及对预防性医疗保健的日益重视,是市场扩张的主要驱动因素。

调查范围
调查期 2024-2030
基准年 2024
预测期 2025-2030
目标单元 金额(十亿美元)
部分 按服务、按用途、按动物类型、按最终用户、按地区
目标区域 北美、欧洲、亚太地区及其他地区

对包括分子诊断、免疫诊断和临床化学检测在内的先进诊断测试的需求日益增长,正在加速已开发经济体和新兴经济体高通量参考实验室的建立。此外,自动化、基于人工智慧的影像分析和分子检测等技术的进步,使得检测结果的交付速度更快,诊断准确性更高,从而进一步加深了兽医和宠物饲主之间的信任。

兽医参考实验室市场-IMG1

同时,诊断服务与数位平台和检查室资讯管理系统(LIMS)的日益整合,正在推动更有效率的工作流程、更完善的检体可追溯性以及对检测结果的远端存取。人们对疾病早期检测和伴侣动物健康管理计画的日益关注,进一步促进了检测的普及;而兽医护理的商业化以及诊所与参考实验室之间日益密切的合作,也带来了源源不断的检体涌入。然而,市场也面临许多挑战,包括高昂的营运和检测成本、熟练的实验室技术人员短缺以及兽医诊断领域严格的监管标准。此外,如何在不同地区保持品质保证,以及如何应对生物安全措施和检体运输方面的挑战,仍然是实验室为维持准确性、可靠性和持续增长而必须优先考虑的关键事项。

根据应用领域,兽医参考实验室市场可细分为临床病理学、细菌学、病毒学、寄生虫学和其他应用。 2024年,临床病理学占了最大的市场。这一主导地位归功于该领域在提供详细的诊断资讯方面发挥的关键作用,这些资讯透过血液学、细胞学和临床化学检测得以提供。这些分析使兽医能够准确诊断全身性疾病、追踪治疗进展并有效管理复杂的病理。伴侣动物数量的增加和兽医就诊频率的上升推动了对常规病理检测服务的需求。此外,自动化分析仪和数位病理系统的技术进步显着提高了诊断的准确性、效率和结果出具时间,进一步促进了该领域的市场成长。

根据最终用户,兽医参考实验室市场可细分为兽医医院和诊所、研究机构和大学、照护现场/内部检查室以及其他最终用户。预计到2024年,兽医诊所和医院将占据全球市场最大的份额。这一主导地位主要归因于越来越多的诊所将分子诊断、免疫诊断和临床化学检测等先进和专业检测外包,以提高诊断的准确性和效率,以及透过与中心实验室合作增加诊断检测量。

伴侣动物数量的增加、宠物医疗支出的增长以及小规模的兽医院网路的扩张,也导致了诊所和医院检体量的增加。这些机构透过依赖参考实验室进行确诊和进行院内无法有效完成的复杂检测,从而改善了治疗效果和工作流程。此外,诊所和参考实验室之间数位化检体管理系统和自动化结果报告系统的整合,缩短了检测结果的周转时间,并支持了实证兽医诊疗。

兽医参考实验室市场分为北美、欧洲、亚太以及中东和非洲四个区域。截至2024年,北美在全球市场中占最大份额。这一主导地位归功于几个关键因素,包括全部区域较高的宠物拥有率、对预防性兽医保健的高度重视以及在医疗费用支出。 IDEXX Laboratories、Zoetis Services LLC 和 Mars, Incorporated 等主要企业的存在,以及完善的兽医医院和诊断中心网络,进一步巩固了该地区的主导地位。在北美,美国占据最大的市场份额,这得益于该国先进的兽医基础设施、对专业和分子诊断测试日益增长的需求,以及自动化和数位病理解决方案的快速普及。此外,美国市场还受益于宠物保险的高渗透率、强大的兽医服务提供者生态系统以及对伴侣动物和牲畜诊断创新研发的积极投资。

本报告对全球兽医参考实验室市场进行了分析,并按服务、应用、动物类型、最终用户、区域趋势以及参与市场的公司的概况进行了细分。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章 市场概览

  • 市场动态
  • 产业趋势
  • 技术分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 监管分析
  • 专利分析
  • 定价分析
  • 报销分析
  • 宠物主人行为
  • 2025-2026 年主要会议和活动
  • 最终使用者观点和未满足的需求
  • 人工智慧/基因工程人工智慧对兽医参考实验室市场的影响
  • 生态系图
  • 在生态系中的作用
  • 价值链分析
  • 投资和资金筹措方案
  • 案例研究分析
  • 影响客户业务的趋势/颠覆性因素
  • 2025年美国关税对兽医检测市场的影响

6. 兽医参考实验室市场(依服务分类)

  • 介绍
  • 临床化学
  • 免疫诊断
  • 分子诊断
  • 血液学
  • 尿液检查
  • 组织病理学和细胞学
  • 微生物学
  • 其他的

7. 兽医参考实验室市场(按应用领域划分)

  • 介绍
  • 临床病理
  • 细菌学
  • 病毒学
  • 寄生虫学
  • 生产力测试
  • 妊娠测试
  • 毒性测试
  • 其他的

8. 兽医参考实验室市场(依动物类型划分)

  • 介绍
  • 伴侣动物
  • 家畜

9. 按最终用户分類的兽医参考实验室市场

  • 介绍
  • 兽医医院和诊所
  • 照护现场/院内检测
  • 兽医研究机构和大学
  • 其他的

10. 各地区兽医参考实验室市场

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 纽西兰
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十一章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2020-2024年收入分析
  • 2024年市占率分析
  • 公司估值矩阵:主要参与企业,2024 年
  • 公司估值矩阵:Start-Ups/中小企业,2024 年
  • 品牌/产品对比
  • 主要企业的研发支出
  • 估值和财务指标
  • 竞争场景

第十二章:公司简介

  • 主要参与企业
    • IDEXX LABORATORIES, INC.
    • MARS, INCORPORATED
    • ZOETIS SERVICES LLC
    • GD(ROYAL GD ANIMAL HEALTH)
    • LABOKLIN GMBH & CO. KG
    • CVS(UK)LIMITED
    • NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS
    • ANIMAL AND PLANT HEALTH AGENCY
    • ICAR-NIVEDI(NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)
    • NATIONAL VETERINARY SERVICES
    • TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY(TVMDL)
    • ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY
    • COLORADO STATE UNIVERSITY(VETERINARY DIAGNOSTIC LABORATORY)
    • BIOBEST LABORATORIES LTD.
    • PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE
  • 其他公司
    • ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON
    • UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY
    • VAXXINOVA
    • MIRA VISTA LABS
    • ELLIE DIAGNOSTICS
    • PROTATEK INTERNATIONAL, INC.
    • THE PIRBRIGHT INSTITUTE
    • CVR LABORATORY(CVRL)
    • VETERINARY PATHOLOGY GROUP
    • FRIEDRICH-LOEFFLER-INSTITUT(FLI)

第十三章附录

Product Code: MD 4362

The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsBy Service, Application, Animal type, End User, Region
Regions coveredNorth America, Europe, APAC, RoW

The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners.

Veterinary Reference Laboratory Market - IMG1

At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.

The clinical pathology segment accounted for the largest share of the market, by application, in 2024.

Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment's critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.

The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.

Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.

The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.

In 2024, North America dominated the veterinary reference laboratory market.

The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region's leadership. Within North America, the United States held the largest market share, supported by the country's advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
  • By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
  • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

  • By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%)
  • By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
  • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Research Coverage

This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.

Reasons to Buy the Report

The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.

This report provides insights into the following points:

  • Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONAL SCOPE
    • 1.3.3 INCLUSIONS & EXCLUSIONS
    • 1.3.4 YEARS CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key sources of secondary research
      • 2.2.1.2 Key objectives of secondary research
      • 2.2.1.3 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key primary sources
      • 2.2.2.2 Key objectives of primary research
      • 2.2.2.3 Key data from primary sources
      • 2.2.2.4 Key industry insights
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 REVENUE SHARE ANALYSIS
    • 2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.3.3 DEMAND-SIDE ANALYSIS
    • 2.3.4 TOP-DOWN APPROACH
    • 2.3.5 BOTTOM-UP APPROACH
  • 2.4 DATA TRIANGULATION
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 STUDY ASSUMPTIONS
    • 2.6.1 MARKET ASSUMPTIONS
    • 2.6.2 GROWTH RATE ASSUMPTIONS
  • 2.7 RISK ANALYSIS
  • 2.8 RESEARCH LIMITATIONS
    • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY PRODUCT AND COUNTRY (2024)
  • 4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX
  • 4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • 5.1.1 DRIVERS
      • 5.1.1.1 Growing routine wellness and oncology screening in companion animals
      • 5.1.1.2 Rapid adoption of digital pathology and telepathology
      • 5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases
      • 5.1.1.4 Growth in companion animal population
      • 5.1.1.5 Rising demand for animal-derived food products
      • 5.1.1.6 Increasing demand for pet insurance and growing animal health expenditure
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 Competition from in-clinic and point-of-care testing
      • 5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Potential growth opportunities in emerging economies
      • 5.1.3.2 Investment in advanced technologies in veterinary reference laboratories
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories
      • 5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories
  • 5.2 INDUSTRY TRENDS
    • 5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES
    • 5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM
  • 5.3 TECHNOLOGY ANALYSIS
    • 5.3.1 KEY TECHNOLOGIES
      • 5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR)
      • 5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS)
      • 5.3.1.3 CRISPR-based diagnostics
    • 5.3.2 ADJACENT TECHNOLOGIES
      • 5.3.2.1 Integrated LIMS and one health surveillance platforms
      • 5.3.2.2 AI-driven diagnostic tools
    • 5.3.3 COMPLEMENTARY TECHNOLOGIES
      • 5.3.3.1 Telepathology
      • 5.3.3.2 Breath and saliva-based diagnostic tools
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.5.2 KEY BUYING CRITERIA
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 REGULATORY LANDSCAPE
      • 5.6.1.1 North America
        • 5.6.1.1.1 US
      • 5.6.1.2 Europe
    • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    • 5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY
    • 5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS
    • 5.7.3 MAJOR PATENTS
  • 5.8 PRICING ANALYSIS
    • 5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022-2024
    • 5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022-2024
  • 5.9 REIMBURSEMENT ANALYSIS
  • 5.10 PET PARENT BEHAVIOUR
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 END-USER PERSPECTIVE & UNMET NEEDS
  • 5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET
    • 5.13.1 INTRODUCTION
    • 5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM
    • 5.13.3 AI-USE CASES
    • 5.13.4 KEY COMPANIES IMPLEMENTING AI
  • 5.14 ECOSYSTEM MAP
  • 5.15 ROLE IN ECOSYSTEM
  • 5.16 VALUE CHAIN ANALYSIS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 CASE STUDY ANALYSIS
    • 5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
    • 5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
    • 5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON COUNTRY/REGION
      • 5.20.4.1 North America
      • 5.20.4.2 Europe
      • 5.20.4.3 Asia Pacific
      • 5.20.4.4 Latin America
    • 5.20.5 IMPACT ON END-USE INDUSTRIES
      • 5.20.5.1 Veterinary hospitals & clinics
      • 5.20.5.2 Point-of-care (POC) and in-house testing setups
      • 5.20.5.3 Veterinary research institutes & universities
      • 5.20.5.4 Other end users

6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE

  • 6.1 INTRODUCTION
  • 6.2 CLINICAL CHEMISTRY
    • 6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE
      • 6.2.1.1 Companion animals
        • 6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth
      • 6.2.1.2 Livestock animals
        • 6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth
  • 6.3 IMMUNODIAGNOSTICS
    • 6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE
      • 6.3.1.1 ELISA
        • 6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection
    • 6.3.2 LATERAL FLOW ASSAYS
      • 6.3.2.1 Technological advancements and cost-effectiveness to aid market growth
    • 6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
      • 6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth
    • 6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES
    • 6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE
      • 6.3.5.1 Companion animals
        • 6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth
      • 6.3.5.2 Livestock animals
        • 6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand
  • 6.4 MOLECULAR DIAGNOSTICS
    • 6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE
    • 6.4.2 PCR TESTS
      • 6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests
    • 6.4.3 MICROARRAYS
      • 6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications
    • 6.4.4 NUCLEIC ACID SEQUENCING
      • 6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth
    • 6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES
    • 6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE
      • 6.4.6.1 Companion animals
        • 6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance
      • 6.4.6.2 Livestock animals
        • 6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence
  • 6.5 HEMATOLOGY
    • 6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE
      • 6.5.1.1 Companion animals
        • 6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth
      • 6.5.1.2 Livestock animals
        • 6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth
  • 6.6 URINALYSIS
    • 6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE
      • 6.6.1.1 Companion animals
        • 6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market
      • 6.6.1.2 Livestock animals
        • 6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment
  • 6.7 HISTOPATHOLOGY & CYTOLOGY
    • 6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE
      • 6.7.1.1 Companion animals
        • 6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market
      • 6.7.1.2 Livestock animals
        • 6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand
  • 6.8 MICROBIOLOGY
    • 6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE
      • 6.8.1.1 Companion animals
        • 6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth
      • 6.8.1.2 Livestock animals
        • 6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand
  • 6.9 OTHER SERVICES
    • 6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE
      • 6.9.1.1 Companion animals
      • 6.9.1.2 Livestock animals

7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL PATHOLOGY
    • 7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET
  • 7.3 BACTERIOLOGY
    • 7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
  • 7.4 VIROLOGY
    • 7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH
  • 7.5 PARASITOLOGY
    • 7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH
  • 7.6 PRODUCTIVITY TESTING
    • 7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH
  • 7.7 PREGNANCY TESTING
    • 7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH
  • 7.8 TOXICOLOGY TESTING
    • 7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH
  • 7.9 OTHER APPLICATIONS

8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 COMPANION ANIMALS
    • 8.2.1 DOGS
      • 8.2.1.1 High insurance coverage and availability of reimbursements to drive market
    • 8.2.2 CATS
      • 8.2.2.1 Increasing pet cat population to support market uptake
    • 8.2.3 HORSES
      • 8.2.3.1 Growing awareness regarding equine health to fuel market growth
    • 8.2.4 OTHER COMPANION ANIMALS
  • 8.3 LIVESTOCK ANIMALS
    • 8.3.1 CATTLE
      • 8.3.1.1 Growing consumption of dairy products to drive market growth
    • 8.3.2 SWINE
      • 8.3.2.1 Increasing incidence of infectious diseases to fuel market growth
    • 8.3.3 POULTRY
      • 8.3.3.1 Increasing demand for poultry meat to spur market growth
    • 8.3.4 SHEEP & GOATS
      • 8.3.4.1 International trade and strict health regulations to drive market
    • 8.3.5 OTHER LIVESTOCK ANIMALS

9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 VETERINARY HOSPITALS & CLINICS
    • 9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS
  • 9.3 POINT-OF-CARE/IN-HOUSE TESTING
    • 9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH
  • 9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
    • 9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES
  • 9.5 OTHER END USERS

10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period
    • 10.2.3 CANADA
      • 10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth
    • 10.3.3 UK
      • 10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Growth of livestock industry and high companion animal population to support market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Rising awareness about pet healthcare to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing demand for pig and poultry products to drive market
    • 10.3.7 NETHERLANDS
      • 10.3.7.1 Increasing animal healthcare expenditure to drive market growth
    • 10.3.8 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Large pool of food-producing animals to drive market
    • 10.4.3 JAPAN
      • 10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth
    • 10.4.4 INDIA
      • 10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing investments in pet services and products to aid market growth
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing pet population in urban households to drive market
    • 10.4.7 THAILAND
      • 10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing
    • 10.4.8 NEW ZEALAND
      • 10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth
    • 10.4.9 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth
    • 10.5.4 ARGENTINA
      • 10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market
    • 10.5.5 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Kingdom of Saudi Arabia
        • 10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth
      • 10.6.2.2 UAE
        • 10.6.2.2.1 Government support and favorable initiatives to fuel market growth
      • 10.6.2.3 Rest of GCC Countries
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
    • 11.4.2 GLOBAL MARKET SHARE ANALYSIS
    • 11.4.3 US MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Service footprint
      • 11.5.5.4 Animal type footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024
      • 11.6.5.1 Detailed list of key startups/SME players
      • 11.6.5.2 Competitive benchmarking of key emerging players/startups
  • 11.7 BRAND/PRODUCT COMPARISON
  • 11.8 R&D EXPENDITURE OF KEY PLAYERS
  • 11.9 COMPANY VALUATION & FINANCIAL METRICS
    • 11.9.1 FINANCIAL METRICS
    • 11.9.2 COMPANY VALUATION
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 SERVICE LAUNCHES & ENHANCEMENTS
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS
    • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 IDEXX LABORATORIES, INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Service launches and enhancements
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 MARS, INCORPORATED
      • 12.1.2.1 Business overview
      • 12.1.2.2 Services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Service launches
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 ZOETIS SERVICES LLC
      • 12.1.3.1 Business overview
      • 12.1.3.2 Services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
        • 12.1.3.3.2 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 GD (ROYAL GD ANIMAL HEALTH)
      • 12.1.4.1 Business overview
      • 12.1.4.2 Services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Service launches
        • 12.1.4.3.2 Deals
        • 12.1.4.3.3 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 LABOKLIN GMBH & CO. KG
      • 12.1.5.1 Business overview
      • 12.1.5.2 Services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Service launches
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 CVS (UK) LIMITED
      • 12.1.6.1 Business overview
      • 12.1.6.2 Services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Service launches
    • 12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS
      • 12.1.7.1 Business overview
      • 12.1.7.2 Services offered
    • 12.1.8 ANIMAL AND PLANT HEALTH AGENCY
      • 12.1.8.1 Business overview
      • 12.1.8.2 Services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Other developments
    • 12.1.9 ICAR-NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)
      • 12.1.9.1 Business overview
      • 12.1.9.2 Services offered
    • 12.1.10 NATIONAL VETERINARY SERVICES
      • 12.1.10.1 Business overview
      • 12.1.10.2 Services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Expansions
        • 12.1.10.3.2 Other developments
    • 12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)
      • 12.1.11.1 Business overview
      • 12.1.11.2 Services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Service launches and enhancements
    • 12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY
      • 12.1.12.1 Business overview
      • 12.1.12.2 Services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Service launches
        • 12.1.12.3.2 Expansions
    • 12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
      • 12.1.13.1 Business overview
      • 12.1.13.2 Services offered
    • 12.1.14 BIOBEST LABORATORIES LTD.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Services offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Expansions
    • 12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE
      • 12.1.15.1 Business overview
      • 12.1.15.2 Services offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON
    • 12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY
    • 12.2.3 VAXXINOVA
    • 12.2.4 MIRA VISTA LABS
    • 12.2.5 ELLIE DIAGNOSTICS
    • 12.2.6 PROTATEK INTERNATIONAL, INC.
    • 12.2.7 THE PIRBRIGHT INSTITUTE
    • 12.2.8 CVR LABORATORY (CVRL)
    • 12.2.9 VETERINARY PATHOLOGY GROUP
    • 12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI)

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
    • 13.3.1 SERVICE ANALYSIS
    • 13.3.2 COMPANY INFORMATION
    • 13.3.3 GEOGRAPHIC ANALYSIS
    • 13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    • 13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
    • 13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
    • 13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 3 VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS
  • TABLE 4 VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS
  • TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009-2023
  • TABLE 6 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
  • TABLE 7 US: AVERAGE PREMIUMS PAID, 2020 VS. 2023
  • TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012-2023 (USD MILLION)
  • TABLE 9 VETERINARY REFERENCE LABORATORY MARKET: PORTER'S FIVE FORCES
  • TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%)
  • TABLE 11 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET
  • TABLE 16 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 17 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 18 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 19 AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 20 AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 21 AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 22 AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION, 2022-2024 (USD)
  • TABLE 23 KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025-DECEMBER 2026
  • TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE LABORATORY MARKET
  • TABLE 25 VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM
  • TABLE 26 CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
  • TABLE 27 CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
  • TABLE 28 CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
  • TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY
  • TABLE 31 IMPACT OF US TARIFF ON CANADA
  • TABLE 32 IMPACT OF US TARIFF ON GERMANY AND UK
  • TABLE 33 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
  • TABLE 34 IMPACT OF US TARIFF ON MEXICO
  • TABLE 35 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 36 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES
  • TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 39 CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
  • TABLE 42 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 44 IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE , 2023-2030 (USD MILLION)
  • TABLE 49 IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES
  • TABLE 52 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 54 MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES
  • TABLE 62 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES
  • TABLE 67 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES
  • TABLE 72 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES
  • TABLE 77 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE LABORATORY SERVICES
  • TABLE 82 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 87 KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES
  • TABLE 88 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES
  • TABLE 90 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 KEY PLAYERS PROVIDING VIROLOGY SERVICES
  • TABLE 92 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 KEY PLAYERS PROVIDING PARASITOLOGY SERVICES
  • TABLE 94 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES
  • TABLE 96 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES
  • TABLE 98 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES
  • TABLE 100 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS
  • TABLE 104 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR DOGS
  • TABLE 107 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 108 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATS
  • TABLE 109 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR HORSES
  • TABLE 111 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS
  • TABLE 114 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATTLE
  • TABLE 117 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR SWINE
  • TABLE 119 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 120 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR POULTRY
  • TABLE 121 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 125 US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD)
  • TABLE 126 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 VETERINARY REFERENCE LABORATORY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 131 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 133 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 142 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 148 US: KEY MACROINDICATORS
  • TABLE 149 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 150 US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 159 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 160 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 161 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 165 CANADA: KEY MACROINDICATORS
  • TABLE 166 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 167 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 176 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 177 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 178 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 182 EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION)
  • TABLE 183 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 184 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 185 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 186 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 194 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 195 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 196 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 200 GERMANY: KEY MACROINDICATORS
  • TABLE 201 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 202 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 203 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 211 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 212 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 213 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 217 UK: KEY MACROINDICATORS
  • TABLE 218 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 219 UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 228 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 229 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 230 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 234 FRANCE: KEY MACROINDICATORS
  • TABLE 235 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 236 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 245 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 246 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 247 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 251 ITALY: KEY MACROINDICATORS
  • TABLE 252 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 253 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 262 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 263 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 264 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 268 SPAIN: KEY MACROINDICATORS
  • TABLE 269 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 270 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 272 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 275 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 279 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 280 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 281 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 285 NETHERLANDS: KEY MACROINDICATORS
  • TABLE 286 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 287 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 290 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 296 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 297 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 298 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 300 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 301 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 302 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 303 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 304 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 310 REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 311 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 312 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 313 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 314 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 317 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 327 ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 329 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 333 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 334 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 335 CHINA: KEY MACROINDICATORS
  • TABLE 336 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 337 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 338 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 340 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 341 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 342 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 CHINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 345 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 346 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 347 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 348 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 351 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 352 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 353 JAPAN: KEY MACROINDICATORS
  • TABLE 354 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 355 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 356 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 357 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 358 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 359 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 360 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 361 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 362 JAPAN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 363 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 364 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 365 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 366 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 367 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 368 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 369 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 370 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 371 INDIA: KEY MACROINDICATORS
  • TABLE 372 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 373 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 374 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 375 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 376 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 377 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 378 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 379 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 380 INDIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 381 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 382 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 383 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 384 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 385 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 386 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 387 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 388 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 389 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 390 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 391 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 392 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 393 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 394 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 395 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 396 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 397 AUSTRALIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 398 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 399 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 400 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 401 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 402 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 403 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 404 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 405 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 406 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 407 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 408 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 409 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 410 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 411 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 412 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 413 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 414 SOUTH KOREA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 415 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 416 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 417 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 418 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 419 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 420 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 421 SOUTH KOREA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 422 THAILAND: KEY MACROINDICATORS
  • TABLE 423 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 424 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 425 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 426 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 427 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 428 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 429 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 430 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 431 THAILAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 432 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 433 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 434 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 435 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 436 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 437 THAILAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 438 THAILAND: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 439 NEW ZEALAND: KEY MACROINDICATORS
  • TABLE 440 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 441 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 442 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 443 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 444 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 445 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 446 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 447 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 448 NEW ZEALAND: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 449 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 450 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 451 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 452 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 453 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 454 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 455 NEW ZEALAND: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 456 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 457 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 458 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 459 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 460 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 461 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 462 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 463 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 464 REST OF ASIA PACIFIC: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 465 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 466 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 467 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 468 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 469 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 470 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 471 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 472 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 473 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 474 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 475 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 476 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 477 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 478 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 479 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 480 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 481 LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 482 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 483 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 484 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 485 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 486 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 487 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 488 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 489 BRAZIL: KEY MACROINDICATORS
  • TABLE 490 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 491 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 492 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 493 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 494 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 495 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 496 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 497 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 498 BRAZIL: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 499 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 500 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 501 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 502 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 503 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 504 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 505 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 506 MEXICO: KEY MACROINDICATORS
  • TABLE 507 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 508 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 509 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 510 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 511 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 512 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 513 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 514 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 515 MEXICO: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 516 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 517 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 518 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 519 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 520 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 521 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 522 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 523 ARGENTINA: KEY MACROINDICATORS
  • TABLE 524 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 525 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 526 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 527 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 528 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 529 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 530 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 531 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 532 ARGENTINA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 533 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 534 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 535 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 536 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 537 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 538 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 539 ARGENTINA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 540 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 541 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 542 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 543 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 544 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 545 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 546 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 547 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 548 REST OF LATIN AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 549 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 550 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 551 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 552 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 553 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 554 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 555 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 556 MIDDLE EAST & ARICA: VETERINARY REFERENCE LABORATORY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 557 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 558 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 559 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 560 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 561 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 562 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 563 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 564 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 565 MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 566 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 567 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 568 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 569 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 570 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 571 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 572 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 573 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 574 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 575 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 576 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 577 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 578 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 579 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 580 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 581 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 582 GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 583 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 584 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 585 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 586 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 587 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 588 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 589 GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 590 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
  • TABLE 591 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 592 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 593 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 594 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 595 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 596 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 597 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 598 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 599 KINGDOM OF SAUDI ARABIA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 600 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 601 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 602 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 603 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 604 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 605 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 606 KINGDOM OF SAUDI ARABIA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 607 UAE: KEY MACROINDICATORS
  • TABLE 608 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 609 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 610 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 611 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 612 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 613 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 614 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 615 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 616 UAE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 617 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 618 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 619 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 620 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 621 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 622 UAE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 623 UAE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 624 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 625 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 626 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 627 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 628 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 629 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 630 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 631 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 632 REST OF GCC COUNTRIES: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 633 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 634 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 635 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 636 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 637 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 638 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 639 REST OF GCC COUNTRIES: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 640 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 641 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 642 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 643 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 644 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 645 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 646 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 647 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 648 REST OF MIDDLE EAST & AFRICA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 649 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 650 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023-2030 (USD MILLION)
  • TABLE 651 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 652 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
  • TABLE 653 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 654 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 655 REST OF MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 656 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET
  • TABLE 657 GLOBAL VETERINARY REFERENCE LABORATORY MARKET: DEGREE OF COMPETITION
  • TABLE 658 US VETERINARY REFERENCE LABORATORY MARKET: DEGREE OF COMPETITION
  • TABLE 659 VETERINARY REFERENCE LABORATORY MARKET: REGION FOOTPRINT
  • TABLE 660 VETERINARY REFERENCE LABORATORY MARKET: SERVICE FOOTPRINT
  • TABLE 661 VETERINARY REFERENCE LABORATORY MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 662 VETERINARY REFERENCE LABORATORY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 663 VETERINARY REFERENCE LABORATORY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
  • TABLE 664 VETERINARY REFERENCE LABORATORY MARKET: SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 665 VETERINARY REFERENCE LABORATORY MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 666 VETERINARY REFERENCE LABORATORY MARKET: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 667 VETERINARY REFERENCE LABORATORY MARKET: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 668 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 669 IDEXX LABORATORIES, INC.: SERVICES OFFERED
  • TABLE 670 IDEXX LABORATORIES, INC.: SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 671 MARS, INCORPORATED: COMPANY OVERVIEW
  • TABLE 672 MARS, INCORPORATED: SERVICES OFFERED
  • TABLE 673 MARS, INCORPORATED: SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 674 MARS, INCORPORATED: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 675 MARS, INCORPORATED: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 676 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 677 ZOETIS SERVICES LLC: SERVICES OFFERED
  • TABLE 678 ZOETIS SERVICES LLC: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 679 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 680 GD (ROYAL GD ANIMAL HEALTH): COMPANY OVERVIEW
  • TABLE 681 GD (ROYAL GD ANIMAL HEALTH): SERVICES OFFERED
  • TABLE 682 GD (ROYAL GD ANIMAL HEALTH): SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 683 GD (ROYAL GD ANIMAL HEALTH): DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 684 GD (ROYAL GD ANIMAL HEALTH): EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 685 LABOKLIN GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 686 LABOKLIN GMBH & CO. KG: SERVICES OFFERED
  • TABLE 687 LABOKLIN GMBH & CO. KG: SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 688 CVS (UK) LIMITED: COMPANY OVERVIEW
  • TABLE 689 CVS (UK) LIMITED: SERVICES OFFERED
  • TABLE 690 CVS (UK) LIMITED: SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 691 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS: COMPANY OVERVIEW
  • TABLE 692 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS: SERVICES OFFERED
  • TABLE 693 ANIMAL AND PLANT HEALTH AGENCY: COMPANY OVERVIEW
  • TABLE 694 ANIMAL AND PLANT HEALTH AGENCY: SERVICES OFFERED
  • TABLE 695 ANIMAL AND PLANT HEALTH AGENCY: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 696 ICAR-NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS): COMPANY OVERVIEW
  • TABLE 697 ICAR-NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS): SERVICES OFFERED
  • TABLE 698 NATIONAL VETERINARY SERVICES: COMPANY OVERVIEW
  • TABLE 699 NATIONAL VETERINARY SERVICES: SERVICES OFFERED
  • TABLE 700 NATIONAL VETERINARY SERVICES: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 701 NATIONAL VETERINARY SERVICES: OTHER DEVELOPMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 702 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): COMPANY OVERVIEW
  • TABLE 703 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): SERVICES OFFERED
  • TABLE 704 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL): SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 705 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: COMPANY OVERVIEW
  • TABLE 706 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICES OFFERED
  • TABLE 707 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 708 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 709 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): COMPANY OVERVIEW
  • TABLE 710 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): PRODUCTS/SERVICES OFFERED
  • TABLE 711 BIOBEST LABORATORIES LTD.: COMPANY OVERVIEW
  • TABLE 712 BIOBEST LABORATORIES LTD.: SERVICES OFFERED
  • TABLE 713 BIOBEST LABORATORIES LTD.: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 714 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE: COMPANY OVERVIEW
  • TABLE 715 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE: SERVICES OFFERED
  • TABLE 716 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON: COMPANY OVERVIEW
  • TABLE 717 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY: COMPANY OVERVIEW
  • TABLE 718 VAXXINOVA: COMPANY OVERVIEW
  • TABLE 719 MIRA VISTA LABS: COMPANY OVERVIEW
  • TABLE 720 ELLIE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 721 PROTATEK INTERNATIONAL, INC.: COMPANY OVERVIEW
  • TABLE 722 THE PIRBRIGHT INSTITUTE: COMPANY OVERVIEW
  • TABLE 723 CVR LABORATORY (CVRL): COMPANY OVERVIEW
  • TABLE 724 VETERINARY PATHOLOGY GROUP: COMPANY OVERVIEW
  • TABLE 725 FRIEDRICH-LOEFFLER-INSTITUT (FLI): COMPANY OVERVIEW

List of Figures

  • FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION
  • FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL SCOPE
  • FIGURE 3 VETERINARY REFERENCE LABORATORY MARKET: YEARS CONSIDERED
  • FIGURE 4 VETERINARY REFERENCE LABORATORY MARKET: RESEARCH DESIGN
  • FIGURE 5 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 6 VETERINARY REFERENCE LABORATORY MARKET: KEY PRIMARY SOURCES
  • FIGURE 7 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8 VETERINARY REFERENCE LABORATORY MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 11 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 12 VETERINARY REFERENCE LABORATORY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 13 VETERINARY REFERENCE LABORATORY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR IDEXX LABORATORIES, INC. (2024)
  • FIGURE 14 REVENUE ANALYSIS OF TOP FIVE COMPANIES IN VETERINARY REFERENCE LABORATORY MARKET (2024)
  • FIGURE 15 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
  • FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET: TOP-DOWN APPROACH
  • FIGURE 17 VETERINARY REFERENCE LABORATORY MARKET: BOTTOM-UP APPROACH
  • FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VETERINARY REFERENCE LABORATORY MARKET (2025-2030)
  • FIGURE 19 VETERINARY REFERENCE LABORATORY MARKET: CAGR PROJECTIONS
  • FIGURE 20 VETERINARY REFERENCE LABORATORY MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 21 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 23 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 24 COMPANION ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 25 LIVESTOCK ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 26 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 27 GEOGRAPHIC SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET
  • FIGURE 28 INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET GROWTH
  • FIGURE 29 CHINA AND CONSUMABLES COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 30 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 31 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
  • FIGURE 32 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2030
  • FIGURE 33 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 34 EUROPE: PET POPULATION (DOGS VS. CATS), 2021-2023 (MILLION)
  • FIGURE 35 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
  • FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORIES
  • FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 39 NUMBER OF GRANTED PATENT APPLICATIONS IN VETERINARY REFERENCE LABORATORY MARKET (JANUARY 2014-SEPTEMBER 2025)
  • FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2014-OCTOBER 2025)
  • FIGURE 41 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC AND URINALYSIS SERVICES, BY KEY PLAYER (2024)
  • FIGURE 42 AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION (2024)
  • FIGURE 43 AI-USE CASES IN VETERINARY REFERENCE LABORATORY MARKET
  • FIGURE 44 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MAP
  • FIGURE 45 VETERINARY REFERENCE LABORATORY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 46 FUNDING AND NUMBER OF DEALS IN VETERINARY REFERENCE LABORATORY MARKET, 2020-2024 (USD MILLION)
  • FIGURE 47 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS' CUSTOMERS IN VETERINARY REFERENCE LABORATORY MARKET
  • FIGURE 48 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020-2030
  • FIGURE 49 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 50 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
  • FIGURE 51 US: POPULATION OF DOGS, 2012-2022 (MILLION)
  • FIGURE 52 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
  • FIGURE 53 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020-2024)
  • FIGURE 54 RANKING OF KEY PLAYERS IN GLOBAL VETERINARY SOFTWARE MARKET, 2024
  • FIGURE 55 GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS (2024)
  • FIGURE 56 US: VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)
  • FIGURE 57 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 58 VETERINARY REFERENCE LABORATORY MARKET: COMPANY FOOTPRINT
  • FIGURE 59 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 60 VETERINARY REFERENCE LABORATORY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 61 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET, 2022-2024
  • FIGURE 62 EV/EBITDA OF KEY VENDORS
  • FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 64 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 65 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
  • FIGURE 66 CVS (UK) LIMITED: COMPANY SNAPSHOT